Cargando…

Comment on “Alemtuzumab improves cognitive processing speed in active multiple sclerosis – a longitudinal observational study”

Detalles Bibliográficos
Autores principales:	Asadollahzade, Elnaz, Ghadiri, Fereshteh, Ebadi, Zahra, Moghadasi, Abdorreza Naser
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Médica Brasileira 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779974/ https://www.ncbi.nlm.nih.gov/pubmed/36449809 http://dx.doi.org/10.1590/1806-9282.20221037

Ejemplares similares

Comment on “The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to in vivo imaging”
por: Asadollahzade, Elnaz, et al.
Publicado: (2022)

Is Monkeypox a Concern in Multiple Sclerosis Patients? A Letter to Editor
por: Asadollahzadeh, Elnaz, et al.
Publicado: (2022)

Beta-thalassemia intermedia with ischemic transients misdiagnosed as multiple sclerosis: A case report
por: Ghadiri, Fereshteh, et al.
Publicado: (2021)

Alemtuzumab Improves Cognitive Processing Speed in Active Multiple Sclerosis—A Longitudinal Observational Study
por: Riepl, Ester, et al.
Publicado: (2018)

Initial clinical presentation of multiple sclerosis with concurrent COVID-19 infection: Case report and literature review
por: Ebadi, Zahra, et al.
Publicado: (2022)

The study of COVID-19 infection following vaccination in patients with multiple sclerosis
por: Ghadiri, Fereshteh, et al.
Publicado: (2022)

Attitudes toward vaccination in patients with multiple sclerosis: A report from Iran
por: Ghadiri, Fereshteh, et al.
Publicado: (2021)

The perspective of Iranian patients with multiple sclerosis on the third dose of COVID-19 vaccine
por: Ghadiri, Fereshteh, et al.
Publicado: (2022)

The first presentation of COVID-19 two hours after vaccination in a patient with multiple sclerosis: Can COVID vaccine provoke cytokine storm in a patient with asymptomatic COVID-19?
por: Ghadiri, Fereshteh, et al.
Publicado: (2021)

Acute disseminated encephalomyelitis (ADEM) following SARS-CoV-2 infection: A case report from Iran
por: Asadollahzade, Elnaz, et al.
Publicado: (2022)

Evaluating the relationship between emotional intelligence and cognitive disorders in patients with Multiple Sclerosis
por: Owji, Mahsa, et al.
Publicado: (2018)

Adverse events reported by Iranian patients with multiple sclerosis after the first dose of Sinopharm BBIBP-CorV
por: Ali Sahraian, Mohammad, et al.
Publicado: (2021)

Telemedicine as a strategic intervention for cognitive rehabilitation in MS patients during COVID-19
por: Ghadiri, Fereshteh, et al.
Publicado: (2022)

Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic review
por: Ghadiri, Fereshteh, et al.
Publicado: (2023)

Acute attack in a patient with multiple sclerosis 2 days after COVID vaccination: a case report
por: Seyed Ahadi, Maral, et al.
Publicado: (2021)

Association of cognitive impairment and quality of life in patients with multiple sclerosis: A cross-sectional study
por: Nabizadeh, Fardin, et al.
Publicado: (2022)

Can multiple sclerosis as a cognitive disorder influence patients’ dreams?
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2013)

COVID-19 vaccine hesitancy in Iranian patients with multiple sclerosis
por: Abbasi, Naghmeh, et al.
Publicado: (2022)

The association between body mass index, demographic and clinical characteristics with cognitive performance in patients with neuromyelitis optica spectrum disorder
por: Rezaeimanesh, Nasim, et al.
Publicado: (2022)

Neuroplasticity in Early Onset Multiple Sclerosis
por: Naser Moghadasi, Abdorreza
Publicado: (2014)

Multiple Sclerosis in Parsis: A Historical Issue
por: NASER MOGHADASI, Abdorreza
Publicado: (2014)

Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment
por: Ghadiri, Fereshteh, et al.
Publicado: (2023)

Encephalopathy associated with COVID-19 in a patient with multiple sclerosis
por: Naser Moghadasi, Abdorreza
Publicado: (2020)

Validation of the Persian version of dysphagia in multiple sclerosis questionnaire for the assessment of dysphagia in multiple sclerosis
por: Jafari, Zahra, et al.
Publicado: (2018)

A 31-year-old female patient with concurrent clinical onset of multiple sclerosis and COVID-19: Possible role of SARS-CoV-2 in the pathogenesis of multiple sclerosis
por: Naser Moghadasi, Abdorreza
Publicado: (2021)

Neuropsychiatric and cognitive effects of the COVID-19 outbreak on multiple sclerosis patients
por: Haji Akhoundi, Fahimeh, et al.
Publicado: (2020)

The big challenge for neurologists in treating patients with multiple sclerosis in the post-COVID-19 era
por: Naser Moghadasi, Abdorreza
Publicado: (2020)

Lack of Attention to the Administration of Fampridine as a Symptomatic Drug in Iranian Multiple Sclerosis Patients
por: Moghadasi, Abdorreza Naser
Publicado: (2021)

Importance of T-cell response to COVID-19 vaccination in patients with multiple sclerosis treated by anti-CD20 therapies: New vaccines are required to be developed
por: Naser Moghadasi, Abdorreza
Publicado: (2021)

Alemtuzumab for Multiple Sclerosis
por: Willis, Mark D., et al.
Publicado: (2016)

Thrombotic microangiopathy associated with interferon-beta treatment in patients with multiple sclerosis
por: Baghbanian, Seyed Mohammad, et al.
Publicado: (2018)

Iranian specialists’ approach to surgery in patients with multiple sclerosis
por: Ghadiri, Fereshteh, et al.
Publicado: (2023)

Bacterial meningitis in a patient with multiple sclerosis receiving Tysabri
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2016)

A Smartphone-based Application for Self-Management in Multiple Sclerosis
por: Mokhberdezfuli, Mahdieh, et al.
Publicado: (2021)

The Possible Direct Correlation between Cognitive Impairment and Fear of Catching COVID-19 among Patients with Multiple Sclerosis
por: Saeedi, Roghayyeh, et al.
Publicado: (2021)

An observational study of alemtuzumab following fingolimod for multiple sclerosis
por: Willis, Mark, et al.
Publicado: (2017)

Ability to gain religious experiences as a part of cognitive abilities
por: Naser Moghadasi, Abdorreza
Publicado: (2014)

Association of Limb-Girdle muscular dystrophy with multiple sclerosis: A case report
por: Arzani, Mahsa, et al.
Publicado: (2018)

Adding erythropoietin to intravenous methylprednisolone in acute treatment of attacks of neuromyelitis optica spectrum disorders: A randomized controlled trial
por: Shafaei, Maryam, et al.
Publicado: (2022)

The co-occurrence of multiple sclerosis and Evans syndrome: A case report
por: Salehizadeh, Saeideh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vmfvgho4fjv53hrpqh0oiapd0q